Convexia Launches: World’s First AI-Maximalist Pharma Company

Convexia recently launched!

‍

^{"Uncover Drug Assets 10x faster"}

^{‍
TL;DR: An AI-maximalist pharma company. They buy drugs, run clinical trials, and then sell for profit.}

‍

🎥 Launch Video

‍

‍Founded by Ayaan Parikh & Rahul Vijayan

‍

Problem

Pharma is the most bloated, antiquated trillion-dollar industry on the planet.

Life-saving drugs are overlooked, abandoned, or shelved because diligence is still done by hand. Slow, costly, and outdated.

‍

Their Solution

Convexia uses agents to operate 10x faster and 20x leaner. Convexia’s AI agents autonomously handle:

• Sourcing – Find hidden early-stage drugs from around the world.
• Scientific diligence – Evaluate drug viability with leading computational biology tools
• Market analysis – Model market size, competition, and IP positioning
• Clinical operations – Simulate trials, flag CMC issues, and discover CROs
• Business development – Match each drug to the right buyer

Test their agents here: https://www.convexia.bio/playground

‍

Their Ask

Before buying and selling drugs themselves, they are running pilots with early customers who want to accelerate their search and evaluation processes.

Here’s who they are looking to meet—see if anyone’s in your network here.

• Small/mid pharma companies (Incyte, Nimbus, Roivant SubCos)
• Biotech VCs (Versant, Atlas, RA Capital)
• Computational biotechs (Recursion, Insitro, Owkin)
• Operators who’ve brought drugs to market

‍

Learn More

^‍

^{🌐 Visit www.convexia.bio to learn more.}

^‍

^{📅 Book a call here.}

^‍

^{📧 Reach the founders here.}

^‍

^{👣 Follow Convexia on LinkedIn.}

‍